Security key
25056L103
Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN)
CUSIP: 25056L103
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 27,817,792
- Total 13F value
- $545,865,000
- Share change
- +2,076,161
- SEC-reported price per share
- $19.89
- Number of holders
- 49
- Value change
- +$37,059,194
- Number of buys
- 31
- Number of sells
- 17
- Shares outstanding
- 62,701,255
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
49
Top holders
10
DSGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Design Therapeutics, Inc. SEC filings
Design Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25056L103
Recent filing periods:
Ownership snapshot
Top reported holders of DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cormorant Asset Managemen...
Disclosed value leader
Cormorant Asset Managemen...
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 8.2%
Showing 1-6 of 15 holder rows.
Quick read
Cormorant Asset Management, LP leads the comparable SEC ownership view at 8.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cormorant Asset Management, LP's linked filing trail.
Comparable ownership
Top 5
Cormorant Asset Management, LP
8.2%
Logos Global Management LP
4.4%
CITADEL ADVISORS LLC
4%
RA CAPITAL MANAGEMENT, L.P.
3.5%
Avoro Capital Advisors LLC
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
Company
|
8.2%
|
$146,409,000
5,114,850 shares
|
— | 31 Mar 2021 |
| Logos Global Management LP |
13F
Company
|
4.4%
|
$81,702,000
2,732,501 shares
|
— | 31 Mar 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
4%
|
$75,788,000
2,534,703 shares
|
— | 31 Mar 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.5%
|
$65,380,000
2,186,636 shares
|
— | 31 Mar 2021 |
| Avoro Capital Advisors LLC |
13F
Company
|
2.3%
|
$39,702,000
1,468,318 shares
|
— | 31 Mar 2021 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
2.3%
|
$42,955,000
1,436,636 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
49
Shares
27,817,792
Rows available
49
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
43
Q2 2021 holders
49
Holder diff
6
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend